What Protagenic Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 7 | 7 |
| Sells | 0 | 0 |
| Total trades | 7 | 7 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 73,530 | 73,530 |
| Disposed | 0 | 0 |
| Net activity | +73,530 | +73,530 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 21 | Open-market buy · P | +20,000 | $0.65 | +$13K | 73,533 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 20 | Open-market buy · P | +16,634 | $0.59 | +$9.81K | 53,533 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 19 | Open-market buy · P | +2,700 | $0.35 | +$945 | 36,899 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 11 | Open-market buy · P | +2,220 | $0.32 | +$710 | 34,199 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 06 | Open-market buy · P | +685 | $0.22 | +$151 | 31,979 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF | Aug 05 | Open-market buy · P | +5,000 | $0.26 | +$1.29K | 31,294 |
| Armen Garo H | EXEC. CHAIR & PRINCIPAL OFF. | Jul 30 | Open-market buy · P | +26,291 | $0.18 | +$4.81K | 26,291 |
| Arrow Alexander K. | Chief Financial Officer | Oct 12 | Open-market buy · P | +8,000 | $0.81 | +$6.48K | 45,815 |
| Arrow Alexander K. | Chief Financial Officer | May 18 | Open-market buy · P | +8,000 | $0.72 | +$5.76K | 151,260 |
| Arrow Alexander K. | Chief Financial Officer | May 17 | Open-market buy · P | +23,000 | $0.71 | +$16.3K | 143,260 |
| Barrage Khalil | Director | May 03 | Exercise / conversion · M | +120,000 | $1.75 | +$210K | 410,000 |
| Barrage Khalil | Director | May 03 | Exercise / conversion · M | +45,000 | $1.75 | +$78.8K | 290,000 |
| Barrage Khalil | Director | May 03 | Exercise / conversion · M | +150,000 | $1.25 | +$188K | 245,000 |
| Barrage Khalil | Director | May 03 | Exercise / conversion · M | +45,000 | $1.25 | +$56.3K | 95,000 |
| Arrow Alexander K. | Chief Financial Officer | Apr 30 | Open-market buy · P | +1,000 | $2.29 | +$2.29K | 120,260 |
| Arrow Alexander K. | Chief Financial Officer | Apr 29 | Open-market buy · P | +1,000 | $2.29 | +$2.29K | 119,260 |
| Barrage Khalil | Director | Aug 08 | Grant / award · A | +150,000 | $1.25 | +$188K | 245,000 |
| Silverman Joshua | Director | Jun 17 | Grant / award · A | +45,000 | $1.25 | +$56.3K | 45,000 |
| Ekizian Gregory | Director | Jun 17 | Grant / award · A | +45,000 | $1.25 | +$56.3K | 645,000 |
| Barrage Khalil | Director | Jun 17 | Grant / award · A | +45,000 | $1.25 | +$56.3K | 245,000 |
Loading...
